poisar

Stocks · News reference

Stephens & Co. Maintains Overweight on Amrize, Lowers Price Target to $54

BenzingaAug 12, 2026, 4:18 PMBenzinga Newsdesk

Stephens & Co. analyst Trey Grooms maintains Amrize (NYSE:AMRZ) with a Overweight and lowers the price target from $65 to $54.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 12, 2026, 4:18 PM
Checked
Aug 12, 2026, 4:18 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARAug 24, 2026, 9:00 PMSEC EDGAR

    8-K filing — Amrize Ltd (AMRZ)

    Filed: 2026-08-24 AccNo: 0001140361-26-034208 Size: 487 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

    Read original at edgar